minimized. Yet, satisfactory treatment also implies prevention and, in the present context, avoidance of cerebral damage. Thus, we have been concerned with the concepts of early diagnosis and early treatment.
Anticoagulants as therapeutic drugs in cerebrovascular disease were suggested by Allen and Barker' more than 10 years ago. Although administered since then for recurrent cerebral emboli, anticoagulant drugs have been little used in the common variety of stroke. The lurking fears of intracerebral hemorrhage, and the causation of gross bleeding into an infarct by such treatment, have been the basis for much wariness. These fears are still present today and suggest caution in the use of anticoagulant therapy. This treatment is not to be recommended at this time as a "routine" for From the Section of Neurology,, Mayo Clinic, Rochester, Minn. Read by title at the meeting of the American Heart Association, New Orleans, October, 1955.
An abstract of this paper appeared in Circulation 12: 775, 1955 . 725 all strokes; it must be sharply limited to certain categories.
Originally it was recalled that a thrombus closing the basilar artery frequently had a laminated appearance. But of more importance were the facts that neurologic abnormalities often progress in steplike fashion when this artery becomes occluded and that transient episodes of neurologic dysfunction are common antecedent occurrences in such patients.2 These observations suggested the usefulness of anticoagulant therapy in preventing the devastating and often fatal result of thrombosis of the basilar artery. Occlusive disease of the basilar arterial system appeared to have a course that might be interrupted by appropriate treatment. The concept of preventing any cerebral damage or more cerebral damage became apparent. In a similar way, episodic symptoms due to insufficiency of the carotid arterial system were looked on also as precursors of occlusion of the internal carotid artery. The results of general and neurologic examinations were normal. He was normotensive. During an attack speech was weak and dysarthric (without evidence of aphasia), the left corner of the mouth drooped, and the tongue, pharynx, and palate moved poorly. Three minutes later the episode was over and examination did not show any abnormalities. Heparin, tromexan, and dicumarol were administered. He had one brief attack just prior to the fifth injection of heparin and none since. Comment. About 50 patients with this lesion have been treated to date with anticoagulant drugs. There have been a striking decrease in mortality (as compared with a contrast group) and surprising improvement in the neurologic abnormalities. Data on the original group showed that 14 per cent of patients receiving anticoagulant therapy died, while 43 per cent of a contrast group (not receiving such therapy) died. 3 Recurrent Cerebral Emboli. These emboli may be associated with atrial fibrillation, rheumatic heart disease and myocardial infarction and they provide another indication for anticoagulant therapy. Wright and McDevitt7 have clearly pointed out the tremendous value of anticoagulants in the preventive treatment of such phenomena.
INDICATIONS
Multiple Strokes. Some patients who appear subject to recurrent cerebral thromboses, presumably supratentorial and often bilateral, also may benefit from anticoagulant therapy in the sense of prevention. Since (1) intermittent insufficiency of the basilar arterial system, (2) intermittent insufficiency of the internal carotid system, (3) thrombosis within the basilar arterial system, (4) recurrent cerebral emboli associated with a likely cardiac source and (5) (2) intermittente insufficientia del systema de carotide interne, (3) thrombosis intra le systema de arteria basilar, (4) recurrent embolos cerebral associate con un probabile origine cardiac, e (5) possibilemente, recurrente thromboses cerebral.
